ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $39,595 | -62.3% | 61,000 | 0.0% | 0.00% | -66.7% |
Q3 2022 | $105,000 | +38.2% | 61,000 | 0.0% | 0.01% | +50.0% |
Q2 2022 | $76,000 | +90.0% | 61,000 | 0.0% | 0.01% | +200.0% |
Q1 2022 | $40,000 | -39.4% | 61,000 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $66,000 | +17.9% | 61,000 | +96.8% | 0.00% | 0.0% |
Q3 2021 | $56,000 | -31.7% | 31,000 | 0.0% | 0.00% | -20.0% |
Q2 2021 | $82,000 | -26.8% | 31,000 | 0.0% | 0.01% | -37.5% |
Q1 2021 | $112,000 | +43.6% | 31,000 | 0.0% | 0.01% | +60.0% |
Q4 2020 | $78,000 | 0.0% | 31,000 | 0.0% | 0.01% | -16.7% |
Q3 2020 | $78,000 | -23.5% | 31,000 | 0.0% | 0.01% | -25.0% |
Q2 2020 | $102,000 | +37.8% | 31,000 | +3.3% | 0.01% | +14.3% |
Q1 2020 | $74,000 | -43.9% | 30,000 | +7.1% | 0.01% | -30.0% |
Q4 2019 | $132,000 | +10.0% | 28,000 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $120,000 | -26.4% | 28,000 | 0.0% | 0.01% | -28.6% |
Q2 2019 | $163,000 | +40.5% | 28,000 | -6.7% | 0.01% | +40.0% |
Q1 2019 | $116,000 | +107.1% | 30,000 | 0.0% | 0.01% | +66.7% |
Q4 2018 | $56,000 | – | 30,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |